Voyageur Pharmaceuticals Market Capitalization vs. Net Asset
| VM Stock | CAD 0.05 0.01 9.09% |
Voyageur Pharmaceuticals Market Cap |
|
For Voyageur Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Voyageur Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Voyageur Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Voyageur Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Voyageur Pharmaceuticals over time as well as its relative position and ranking within its peers.
Voyageur |
Voyageur Pharmaceuticals Net Asset vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Voyageur Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Voyageur Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Voyageur Pharmaceuticals is rated first in market capitalization category among related companies. It is rated first in net asset category among related companies making up about 0.31 of Net Asset per Market Capitalization. The ratio of Market Capitalization to Net Asset for Voyageur Pharmaceuticals is roughly 3.21 . At this time, Voyageur Pharmaceuticals' Market Cap is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Voyageur Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Voyageur Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Voyageur Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Voyageur Market Capitalization vs. Competition
Voyageur Pharmaceuticals is rated first in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 1.37 Trillion. Voyageur Pharmaceuticals adds roughly 6.94 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Voyageur Net Asset vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Voyageur Pharmaceuticals |
| = | 6.94 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Voyageur Pharmaceuticals |
| = | 2.16 M |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Voyageur Net Asset Comparison
Voyageur Pharmaceuticals is currently under evaluation in net asset category among related companies.
Voyageur Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Voyageur Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Voyageur Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Voyageur Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Voyageur Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 10.5 K | 10 K | |
| Operating Income | -1.2 M | -1.2 M | |
| Income Before Tax | -1.3 M | -1.2 M | |
| Net Loss | -1.3 M | -1.2 M | |
| Net Loss | -1.3 M | -1.3 M | |
| Total Other Income Expense Net | -47.8 K | -45.4 K | |
| Net Loss | -1.8 M | -1.8 M | |
| Income Tax Expense | 5.75 | 5.46 | |
| Net Interest Income | -4 K | -4.2 K | |
| Change To Netincome | 848.2 K | 890.7 K | |
| Net Loss | (0.05) | (0.05) | |
| Income Quality | 0.67 | 0.64 | |
| Net Income Per E B T | 0.90 | 0.80 |
Voyageur Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Voyageur Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Voyageur Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Voyageur Pharmaceuticals' important profitability drivers and their relationship over time.
Use Voyageur Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Voyageur Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyageur Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Voyageur Pharmaceuticals Pair Trading
Voyageur Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Voyageur Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Voyageur Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Voyageur Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Voyageur Pharmaceuticals to buy it.
The correlation of Voyageur Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Voyageur Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Voyageur Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Voyageur Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Voyageur Pharmaceuticals position
In addition to having Voyageur Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Air Thematic Idea Now
Air
Companies specializing in air services and air delivery. The Air theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Air Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Voyageur Stock analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
To fully project Voyageur Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Voyageur Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Voyageur Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.